Sacubitril / Valsartan (Entresto)

Cardiology (ARNI - ARB + Neprilysin Inhibitor)

Dosing & Administration

Adult Dose

24/26 mg to 97/103 mg PO BID.

Pediatric Dose

Weight-based for pediatric heart failure.

Renal Adjustment

eGFR < 30: Start at 24/26 mg BID.

Hepatic Adjustment

Child-Pugh B: Start at 24/26 mg BID. Child-Pugh C: Avoid.

Safety & Special Populations

Pregnancy Category

D - Teratogenic.

Lactation Safety

Not recommended.

Contraindications & Adverse Effects

Contraindications

  • History of angioedema
  • Concurrent ACE inhibitor use (must wait 36 hours after stopping ACEi)

Common Adverse Effects

  • Hypotension
  • Hyperkalemia
  • Angioedema
  • Renal impairment